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Pulmonary arteriovenous malformations and embolic myocardial infarction identified with 1 
Cardiovascular magnetic resonance. 2 
 3 
A 42 year old female developed central chest pain radiating to the left shoulder. 12 lead ECG 4 
demonstrated no ischaemia and the serum troponin was raised at 28 (normal < 13ng/L), which peaked 5 
to 140 and fell to 67. Dual antiplatelet therapy with aspirin and clopidogrel was commenced for a 6 
presumed acute coronary syndrome. Transthoracic echocardiography demonstrated preserved 7 
biventricular function and mild mitral regurgitation. Invasive coronary angiography demonstrated 8 
unobstructed coronary arteries and no coronary atheroma. A cardiovascular magnetic resonance 9 
(CMR) scan was arranged to investigate aetiology of the clinical presentation.  10 
Initial low resolution CMR images demonstrated two hyperintense rounded subpleural solid nodules in 11 
the right lung (Panel A). Two, three and four chamber cine imaging confirmed good biventricular 12 
function. Short axis cine imaging demonstrated a subtle regional motion wall abnormality (RMWA) in 13 
the mid septal wall, which was not clearly evident on transthoracic echocardiography, and corresponded 14 
to an area of focal transmural myocardial enhancement on late gadolinium enhancement (LGE) imaging 15 
(Panel B). To further investigate the clinical presentation and right lung mass, 4D angiography was 16 
acquired during intravenous administration of 0.1mmol/kg of gadobutrol (Gadovist, Bayer, Germany). 17 
Multiple pulmonary arteriovenous malformations (AVM) were identified, with afferent (feeding) and 18 
efferent (draining) vessels which enhanced almost simultaneously (Panel C). In the context of 19 
unobstructed coronary arteries, mid septal RMWA, corresponding LGE and pulmonary AVMs, these 20 
findings were in keeping with a paradoxical embolic myocardial infarction. Antiplatelet therapy was 21 
stopped, and anticoagulation with warfarin was commenced. Clinical follow-up confirmed preserved 22 
biventricular function on echocardiography.   23 
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Figure  24 
 25 
 26 
Panel A: Initial scout images demonstrates a subpleural hyperintense rounded solid nodule in the right 27 
lung (red arrow). Panel B: Late gadolinium enhancement imaging demonstrated a focal area of 28 
transmural myocardial enhancement indicating myocardial infarction (arrowed). Panel C: Maximum 29 
intensity projections (MIP) images of the dynamic 4D angiography images. Multiple nodules and 30 
serpiginous masses are present which indicate pulmonary arteriovenous malformations (red arrows).  31 
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Supplementary data (videos) 33 
 34 
Video 1. Parasternal long axis cine on transthoracic echocardiography.  35 
Video 2. 4 Chamber apical view on transthoracic echocardiography. Good biventricular function is 36 
seen, with no regional motion wall abnormality. 37 
Video 3. Unobstructed right coronary artery on invasive coronary angiography. 38 
Video 4. Unobstructed left circumflex artery on invasive coronary angiography. 39 
Video 5. Unobstructed left anterior descending artery on invasive coronary angiography. 40 
Video 6. Four, two and three chamber cine images with CMR. No clear regional motion wall abnormality 41 
is seen.  42 
Video 7. Short axis cine at the mid left ventricle: There is subtle hypokinesia of the mid ventricular 43 
septum.  44 
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